Quarter Results Sandoz reports strong biosimilars growth in Q1 2026; full-year 2026 guidance confirmed 29-Apr-2026 / 07:00 CET/CEST Release of an ad hoc announcement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results